Any questions? Contact us+49 761-389 49-0
To our Austria Webshop
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer recognition
Customer-specific caching
Individual prices
PayPal payments
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Statistics & Tracking
Affiliate program
Google Tag Manager
Track device being used
Close filters
Filter by:
Date
Tags
Filter

Understanding and Clarifying the Complexities of HRD Measurements in Cancer

23 Feb 2022
Understanding and Clarifying the Complexities of HRD Measurements in Cancer
• Ravindra Kolhe, MD, PhD • David Fabrizio, PhD • John Jiang, PhD • Yves Konigshofer, PhD
• available On Demand at genomeweb
Read more
Tags: LGC Clinical Diagnostics, Immuno-Oncology, Reference Materials, Seraseq, LGC Seracare, Referenzmaterial, Tumor Profiling, HRD, Biomarker, ADP-Ribose, PARPi, Oncology

Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing

17 Feb 2022
Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing
• Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
Read more
Tags: Invivoscribe, Leukemia , Multiple Myeloma, Morbus Kahler , Leukämie, ALL , Akute Lymphatische Leukämie, MRD, Messbare (minimale) Resterkrankung (MRD), Minimal Residual Disease (MRD)

The use of Seraseq® Oncology controls & NGS validation challenges

7 Feb 2022
The use of Seraseq® Oncology controls & NGS validation challenges
Video recording of the lecture:
- Tumor Profiling - Liquid Biopsy -Immuno-Oncology
Read more
Tags: LGC Clinical Diagnostics, Immuno-Oncology, Liquid Biopsy, Reference Materials, LoD, Nachweisgrenze, Sensitivität, Seraseq, LGC Seracare, Referenzmaterial, Tumor Profiling
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent.
Decline Accept all Configure